ECM
ExodusPoint Capital Management Portfolio holdings
AUM
$8.21B
1-Year Return
14.38%
This Quarter Return
+3.14%
1 Year Return
+14.38%
3 Year Return
+47.96%
5 Year Return
+100.26%
10 Year Return
–
AUM
$8.56B
AUM Growth
-$194M
(-2.2%)
Cap. Flow
-$460M
Cap. Flow
% of AUM
-5.37%
Top 10 Holdings %
Top 10 Hldgs %
12.91%
Holding
2,266
New
641
Increased
479
Reduced
581
Closed
549
Top Buys
| 1 |
Global Payments
GPN
|
+$295M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$75.5M |
| 3 |
American Homes 4 Rent
AMH
|
+$72.5M |
| 4 |
Equinix
EQIX
|
+$54.8M |
| 5 |
Americold
COLD
|
+$52.5M |
Top Sells
| 1 |
NiSource
NI
|
+$76.6M |
| 2 |
Linde
LIN
|
+$74M |
| 3 |
DTE Energy
DTE
|
+$56.4M |
| 4 |
Freeport-McMoran
FCX
|
+$54.3M |
| 5 |
FedEx
FDX
|
+$48.7M |
Sector Composition
| 1 | Industrials | 15.92% |
| 2 | Technology | 13.97% |
| 3 | Healthcare | 13.1% |
| 4 | Real Estate | 9.85% |
| 5 | Utilities | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Eversource Energy
ES
$24.4B
| $3.57M | 0.03% |
50,339
-109,218
| -68% | -$7.75M |
|
|
MRTX
502
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.57M | 0.03% |
98,738
-65,004
| -40% | -$2.35M |
|
|
VERV
503
DELISTED
Verve Therapeutics
VERV
| $3.56M | 0.03% |
190,071
-73,549
| -28% | -$1.38M |
|
504
Ingredion
INGR
$8.09B
| $3.56M | 0.03% |
+33,609
| New | +$3.56M |
|
505
Replimune Group
REPL
$447M
| $3.53M | 0.03% |
152,138
+27,913
| +22% | +$648K |
|
506
AT&T
T
$211B
| $3.53M | 0.03% |
221,463
-246,357
| -53% | -$3.93M |
|
507
Tarsus Pharmaceuticals
TARS
$2.08B
| $3.52M | 0.03% |
+194,821
| New | +$3.52M |
|
508
Xencor
XNCR
$613M
| $3.5M | 0.03% |
140,112
+24,817
| +22% | +$620K |
|
509
Rexford Industrial Realty
REXR
$10.3B
| $3.5M | 0.03% |
66,945
+40,821
| +156% | +$2.13M |
|
510
MGIC Investment
MTG
$6.55B
| $3.48M | 0.03% |
220,614
+42,130
| +24% | +$665K |
|
511
Crinetics Pharmaceuticals
CRNX
$3.2B
| $3.46M | 0.03% |
191,974
+44,858
| +30% | +$808K |
|
512
Integra LifeSciences
IART
$1.17B
| $3.45M | 0.03% |
83,891
+53,049
| +172% | +$2.18M |
|
513
Merit Medical Systems
MMSI
$5.07B
| $3.44M | 0.03% |
41,079
-130,922
| -76% | -$11M |
|
514
T-Mobile US
TMUS
$272B
| $3.43M | 0.03% |
24,710
-187,576
| -88% | -$26.1M |
|
515
Houlihan Lokey
HLI
$14.4B
| $3.42M | 0.03% |
34,754
-9,631
| -22% | -$947K |
|
516
Tanger
SKT
$3.86B
| $3.42M | 0.03% |
+154,771
| New | +$3.42M |
|
517
Agios Pharmaceuticals
AGIO
$2.14B
| $3.41M | 0.03% |
120,363
-78,003
| -39% | -$2.21M |
|
|
TXNM
518
TXNM Energy, Inc.
TXNM
$5.99B
| $3.4M | 0.03% |
75,462
+769
| +1% | +$34.7K |
|
519
Toll Brothers
TOL
$13.8B
| $3.38M | 0.03% |
42,747
-143,949
| -77% | -$11.4M |
|
520
Cardinal Health
CAH
$36.4B
| $3.38M | 0.03% |
35,709
-131,137
| -79% | -$12.4M |
|
521
Healthpeak Properties
DOC
$12.6B
| $3.33M | 0.03% |
165,419
-268,098
| -62% | -$5.39M |
|
522
Tandem Diabetes Care
TNDM
$829M
| $3.32M | 0.03% |
135,362
+12,279
| +10% | +$301K |
|
523
Organogenesis Holdings
ORGO
$625M
| $3.3M | 0.03% |
994,624
-25,777
| -3% | -$85.6K |
|
524
Mineralys Therapeutics
MLYS
$2.88B
| $3.3M | 0.03% |
193,525
+12,213
| +7% | +$208K |
|
525
UFP Industries
UFPI
$5.78B
| $3.29M | 0.03% |
33,860
-45,350
| -57% | -$4.4M |
|